Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07214636 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development and Investigation of the ApneaTheraPlay

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Aug 1, 2027 → Sep 1, 2027
See other at-risk trials from Medipol University

Record History

  1. Recruitment opened Primary completion pushed from Aug 1, 2027 to Sep 1, 2027 · Completion pushed from Dec 1, 2027 to Apr 1, 2028 · Start date changed from estimate of Jul 28, 2026 to Sep 23, 2026 · 4 more Show 7 more changesShow less
    • Primary completion pushed from Aug 1, 2027 to Sep 1, 2027
    • Completion pushed from Dec 1, 2027 to Apr 1, 2028
    • Start date changed from estimate of Jul 28, 2026 to Sep 23, 2026
    • Eligibility criteria expanded, about 21 words
    • Secondary endpoints: details revised at 20 of 22 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Start date: May 2, 2026 to Jul 28, 2026v3
  3. Start date: Dec 1, 2025 to May 2, 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Obstructive Sleep Apnea Syndrome (OSAS) is commonly treated with CPAP devices, but adherence rates are low. Exercise has been shown to strengthen respiratory muscles, improve upper airway function, and enhance sleep quality. However, most studies have examined only single or dual exercise protocols, and there is little evidence regarding integrated programs with four exercise types or their effects when performed directly before sleep. This project aims to develop and evaluate ApneaTheraPlay (ATP), a digital gamified video-based exercise platform combining respiratory, aerobic, strengthening, and oropharyngeal exercises. The randomized controlled, double-blind study will allocate participants into three groups: ATP, a structured pre-sleep exercise group (SPEG), and a control group (CG). Intervention groups will exercise three times per week for 12 weeks, while the control group will only keep a physical activity diary.
Trial Details
NCT Number NCT07214636
Lead Sponsor Medipol University
Conditions Apnea, Obstructive, Exercise Addiction, Physiotherapy and Rehabilitation
Enrollment 54 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov